Adlai Nortye Ltd., a clinical-stage company, together with its subsidiaries, engages in the research and develops pharmaceutical products. Its product pipeline comprises AN0025, a small molecule EP4 antagonist which is in phase Ib and radio...
FY 2025
Feb 25, 2026
FY 2024
Apr 30, 2025
Q2 2024
Aug 8, 2024
Q1 2024
Mar 31, 2024
FY 2023
Feb 28, 2024